U.S. Reform, Global Markets . . .
Ziopharm's Bet: Cancer Pills Will Beat I.V.; Off-On Method Intrigues
By Randy Osborne
Monday, November 16, 2009
"Ruthlessly efficient" is how Jonathan Lewis, CEO and chief medical officer of Ziopharm Oncology Inc., last week described his firm's approach to research and financial management.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.